Mitochondrial respiratory capacity, sperm motility linked

Mitochondrial respiratory capacity, sperm motility linked
Sperm with higher motility have increased mitochondrial respiratory capacity, according to a study published in the April issue of Urology.

(HealthDay) -- Sperm with higher motility have increased mitochondrial respiratory capacity, according to a study published in the April issue of Urology.

Alessandra Ferramosca, of the University of Salento in Lecce, Italy, and colleagues investigated whether sperm mitochondrial respiratory efficiency correlated with and sperm morphologic anomalies. They used a polarographic assay of to evaluate the mitochondrial respiratory activity of hypotonically-treated .

The researchers observed a positive correlation between mitochondrial respiratory efficiency and sperm motility and a negative correlation with the percentage of immotile sperm. Mitochondrial functionality was impaired in sperm with midpiece defects.

"The results reported in this study support a strong and positive correlation between mitochondrial respiratory efficiency and sperm progressive motility. In addition and in strict agreement with these findings, morphologic alterations of the sperm midpiece, where mitochondria are found, are associated with lower mitochondrial functionality and lower sperm motility," the authors write. "These results confirm the important role played by mitochondria in supplying for sperm motility and provide more insights into the biochemical basis of mitochondria-based asthenozoospermia."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Overweight men have poorer sperm count

Jul 04, 2011

Overweight or obese men, like their female counterparts, have a lower chance of becoming a parent, according to a comparison of sperm quality presented at a European fertility meeting Monday.

Researchers Develop Test to Identify 'Best' Sperm

May 20, 2010

(PhysOrg.com) -- Researchers at Yale School of Medicine have discovered a method to select sperm with the highest DNA integrity in a bid to improve male fertility. The method is comparable to that of the egg’s ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments